Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry

Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients

(2013) Lukas Schwentner et al.   BMC CANCER

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

(2013) E. C. Inwald et al.   BREAST CANCER RESEARCH AND TREATMENT

Trastuzumab-related cardiac events in the treatment of early breast cancer

(2013) Georgeta Fried et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer

(2013) Christopher R. Friese et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

(2013) M. Campiglio et al.   BREAST CANCER RESEARCH AND TREATMENT

Epidemiology of Breast Cancer - Current Figures and Trends

(2013) N. Eisemann et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer

(2013) R. Kreienberg et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of small HER2 overexpressing tumours

(2012) Arnoud Templeton et al.   BREAST CANCER RESEARCH AND TREATMENT

Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis

(2012) W. van de Water et al.   BRITISH JOURNAL OF SURGERY

Current approaches and future directions in the treatment of HER2-positive breast cancer

(2012) Sara A. Hurvitz et al.   CANCER TREATMENT REVIEWS

Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab

(2012) M. D. Seal et al.   Current Oncology

Emerging strategies for the dual inhibition of HER2-positive breast cancer

(2012) Gottfried E. Konecny   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Participation in adjuvant clinical breast cancer trials: Does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients

(2012) L. Schwentner et al.   EUROPEAN JOURNAL OF CANCER

Advances in Breast Cancer – Looking Back over the Year

(2012) D. Lüftner et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Breast Cancer: State of the Art and New Findings

(2012) C. Melcher et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Biomarkers in Breast Cancer – An Update

(2012) M. Schmidt et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Breast Cancer 2012 - New Aspects

(2012) H.-C. Kolberg et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

The Effect of Prolonged Fixation on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Cancer

(2011) Leung Chu Tong et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: A multi-centre cohort study of 5292 patients

(2011) Lukas Schwentner et al.   BREAST

Management and Outcome of HER2-Positive Early Breast Cancer Treated With or Without Trastuzumab in the Adjuvant Trastuzumab Era

(2011) Carlo Palmieri et al.   Clinical Breast Cancer

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial

(2011) Luca Gianni et al.   LANCET ONCOLOGY

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

(2011) Dennis Slamon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services

(2010) Paul S. Craft et al.   BREAST

Effects of guideline adherence in primary breast cancer–A 5-year multi-center cohort study of 3976 patients

(2010) Achim Wöckel et al.   BREAST

Rational use of trastuzumab in metastatic and locally advanced breast cancer: Implications of recent research

(2010) Shom Goel et al.   BREAST

Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study

(2009) K. Hancke et al.   ANNALS OF ONCOLOGY

Breast Cancer in the Elderly: Retrospective Study on Diagnosis and Treatment According to National Guidelines

(2009) Marije E. Hamaker et al.   Breast Journal

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial

(2009) Marc Spielmann et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

(2009) Heikki Joensuu et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review

(2009) Shaheenah Dawood et al.   JOURNAL OF CLINICAL ONCOLOGY

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score

(2008) S. Ménard et al.   ANNALS OF ONCOLOGY